Raycaster

Raycaster

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

An AI platform for computational drug discovery and protein engineering.

AI / Machine Learning

Technology Platform

A deep learning platform for predicting protein structures, interactions, and designing novel molecules with desired properties.

Opportunities

High demand from pharma for tools that can reduce R&D costs and failure rates presents a major growth opportunity.

Risk Factors

If their AI predictions fail to translate into real-world, clinically viable compounds, the business model is at risk.

Competitive Landscape

Part of a highly competitive field of AI drug discovery companies, requiring constant technological innovation.